Dr Arthur Reingold | Professor and Division Head Epidemiology, Former ACIP Member
UC Berkeley School of Public Health

Dr Arthur Reingold, Professor and Division Head Epidemiology, Former ACIP Member, UC Berkeley School of Public Health

Arthur Reingold, MD is Professor of Epidemiology and Head of the Division of Epidemiology at the School of Public Health, University of California, Berkeley. Before joining the faculty of UC Berkeley in 1987, Dr. Reingold worked for eight years as a medical epidemiologist at the U.S. Centers for Disease Control and Prevention. Dr. Reingold is known nationally and internationally for his work over the past 30+ years on the prevention and control of infectious diseases, including those acquired from the environment (e.g. Legionnaires’ disease) and those transmitted from person-to-person (e.g. influenza and other causes of respiratory tract infections). His research collaborations nationally and internationally have led to almost 350 original research publications, which have appeared in the leading journals in the fields of medicine, epidemiology, infectious diseases, and public health. Because of his expertise and experience, he has served on numerous advisory committees and panels for the World Health Organization (e.g. the Strategic Advisory Group of Experts), NIH (e.g. the External Advisory Committee of the Fogarty International Center), and CDC (e.g. the Advisory Committee on Immunization Practices), as well as the State of California and diverse foundations and funding organizations. In recognition of his experience and expertise in epidemiology, Dr. Reingold has been elected President of the Society for Epidemiological Research (SER) and the American Epidemiology Society (AES) and elected to fellowship in diverse scientific and medical groups (e.g. the Infectious Diseases Society of American and the American Association for the Advancement of Science). He was elected to membership in the Institute of Medicine (now the National Academy of Medicine) in 2003 and has served on numerous IOM/NAM committees since that time. He has also given numerous invited lectures, including the Thomas Francis Lecture at the University of Michigan, and he regularly teaches courses on epidemiologic methods and their application at UC Berkeley and in Brazil, Hong Kong, and Switzerland.


DC Pre-congress WS day April 2 @ 2:00

Workshop C: Market access & regulatory challenges in vaccines

The market access landscape for vaccines is more complex than most. Various obstacles are creating a disproportionate move away from investing in preventative interventions and vaccines. Recommendation from the ACIP is an important step towards funding and getting a vaccine to market. 

Join us at the workshop to understand the key components of the ACIPs decisions to recommend and fund and how industry can facilitate this process. Learn how to cope with the obstacles to make sure we get optimal value for our vaccines and discover the pit falls to avoid when launching a new vaccine.

Recommendations and Funding: What are the key components to the ACIPs evaluation of vaccines?

The Value of Vaccination 

Accelerating Access to Vaccines: A manufacturer’s perspective​

back to speakers